Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00117403 · ClinicalTrials.gov registry record · Phase 1
Anti-Oxidant Treatment of Alzheimer's Disease
A Phase 1 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 1
- Development phase
- 75
- Enrollment target
NCT00117403: Completed Phase 1 study, sponsored by National Institute on Aging (NIA).
NCT00117403 is a Phase 1 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 75 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00117403, a Phase 1 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).
Interventions
- DRUG Placebo capsules
- DRUG Vitamin E, Vitamin C, and Alpha-lipoic Acid
- DRUG Coenzyme Q
- DRUG Placebo wafers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2006-01 |
| Est. Completion | 2007-09 |
| Phase | Phase 1 |
What the finished NCT00117403 record still lists
NCT00117403 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (25% higher).
The record links to 0 conditions, and to 4 interventions - of which Placebo capsules is the first listed.
NCT00117403 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00117403 about?
NCT00117403 is a clinical study titled "Anti-Oxidant Treatment of Alzheimer's Disease". The purpose of this study is to examine the safety and effectiveness of two anti-oxidant treatment regimens in patients with mild to moderate Alzheimer's disease. The anti-oxidant treatments include vitamin E + C + alpha-lipoic acid, and Coenzyme Q (CoQ).
What is the current status of trial NCT00117403?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 75 participants. The study started on 2006-01. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00117403?
The interventions under investigation include: Placebo capsules (DRUG), Vitamin E, Vitamin C, and Alpha-lipoic Acid (DRUG), Coenzyme Q (DRUG), Placebo wafers (DRUG).
Who is sponsoring clinical trial NCT00117403?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00117403's enrollment target sits among peer trials
75 711th of 2000 higher than 1,276 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia